
AUTL
USDAutolus Therapeutics plc American Depositary Share
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.520
High
$1.535
Low
$1.400
Volume
2.28M
Company Fundamentals
Market Cap
375.3M
Industry
Biotechnology
Country
United Kingdom
Trading Stats
Avg Volume
3.73M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target
Needham analyst Gil Blum reiterates Autolus Therapeutics with a Buy and maintains $10 price target.
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2025
LONDON and GAITHERSBURG, Md., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation
Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology Convergence 2025
Data from the Phase 1 CARLYSLE study in severe refractory systemic lupus erythematosus (srSLE) suggests obe-cel is well tolerated with no ICANS or high-grade CRS; 50 million cell dose selected for Phase 2 pivotal
Related Stocks
UTHR
United Therapeutics Corporation
NRC
National Research Corporation (Delaware)
BFRGW
Bullfrog AI Holdings Inc. Warrants
OMGA
Omega Therapeutics Inc.
LFVN
Lifevantage Corporation (Delaware)
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.